(Q33902738)

English

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Karina Dahl Steffensen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Marianne Waldstrøm

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Rikke Kølby Christensen

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Annette Bartels

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nils Brünner

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Anders Jakobsen

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

7 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

185

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

CA-125 criteria for response evaluation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

TIMP1 and adverse prognosis in non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

29 October 2018

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of tissue inhibitor of metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-185

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33902738&oldid=2195961536"